Novel Oral GLP-1 Agent Cuts A1c, Weight in Early Diabetes
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A novel oral GLP-1 agent has been found to lower A1c and weight in early diabetes. The agent, possibly called orforglipron, may be part of a new class of oral GLP-1 receptor agonist therapies. It is unclear if this agent has been approved or if it is one of several new weight loss drugs being developed.
Full coverage
1
Pharmacy Times·May 202
Drug Discovery News·Feb 33Pharmacy Times·Jan 64
GoodRx·Nov 295
American Heart Association Journals·Dec 126
Medscape·Jun 26